fbpx

EMERGERS

Equity Research of
Nordic Growth Companies

GRANGEX: Pushing ahead with dual mines in the face of double delays

2023-11-22• Analys, Research

GRÄNGESBERG EXPLORATION Facing delays in both financing and operational development, the current cash at SEK 43.6m means that GRANGEX must...

Read More →

NANEXA: Raising our LOAs following a review of the projects

2023-11-21• Analys, Research

With the dust settling after the recent rights issue, Nanexa now progresses with its more focused roadmap, concentrating on Phase I trials...

Read More →

MOTION DISPLAY: European sales growth offsetting inconsistent US market

2023-11-17• Analys, Research

Motion Display is sustaining its positive momentum with 193% YoY growth and improved cost control, resulting in a third consecutive quarter...

Read More →

AGTIRA: New LOIs propel Agtira towards profitability

2023-11-16• Analys, Research

With a third quarter in line with expectations and a cash injection of SEK 70m following a rights issue, Agtira is making significant...

Read More →

NANEXA: Outcome of rights issue forces an investor-friendly focus on core projects

2023-11-01• Analys, Research

With a subscription rate of 34.7% of the rights issue, and a utilization of guarantee commitments corresponding to 27.1%, Nanexa is...

Read More →

KEBNI: Mixed bag in Q3 – steep growth ahead

2023-11-01• Analys, Research

Despite 29% top-line growth in Q3’23, sales were a bit soft due to a slower-than-anticipated ramp-up of deliveries to Saab. This has led...

Read More →

CRUNCHFISH: Videointervju med CEO Joachim Samuelsson om prospektet, vägen framåt i Indien och framstegen inom AR/VR

2023-10-16• Okategoriserade

Efter att ha signerat ett första kommersiellt avtal med IDFC First Bank under sommaren förbereder sig Crunchfish nu för en stundande...

Read More →

KEBNI: Site visit provided clarity on scale-up and insight into ScaffSense venture

2023-10-16• Analys, Research

Our site visit to KebNi’s new production facility in Karlskoga not only showed production up and running, but also how it can scale...

Read More →

NANEXA: Variable roadmap with emphasis on NEX-22 and potential Novo Nordisk deal

2023-10-11• Analys, Research

With the recently completed Phase 1 study for NEX-20 yielding positive results, and the widespread global interest in GLP-1, Nanexa now has...

Read More →

FREE2MOVE: High-growth niches within energy efficiency

2023-10-04• Analys, Research

With unpredictable energy prices and an urgent green transition, the need for energy efficiency measures has never been higher. Through its...

Read More →

Actionable Investment Research | Sectors & Themes | Shorts and Frauds

Widmark Research 

CONTACT

Johan Widmark

Mail: johan@emergers.se
Tel: +46739196641

Östermalmsgatan 26A
114 26 Stockholm, Sweden

For new research on growth stocks, sign up to our newsletter